Fewer Dollars, More Sense

被引：0

作者：

Garfield, David H. ^{[1
]}

Hercbergs, Aleck ^{[2
]}

机构：

[1] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA

[2] Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 32期

关键词：

D O I：

10.1200/JCO.2008.17.9564

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：5304 / 5305

页数：2

共 18 条

[1] AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients [J].

Batchelor, Tracy T. ;

Sorensen, A. Gregory ;

di Tomaso, Emmanuelle ;

Zhang, Wei-Ting ;

Duda, Dan G. ;

Cohen, Kenneth S. ;

Kozak, Kevin R. ;

Cahill, Daniel P. ;

Chen, Poe-Jou ;

Zhu, Mingwang ;

Ancukiewicz, Marek ;

Mrugala, Maciej M. ;

Plotkin, Scott ;

Drappatz, Jan ;

Louis, David N. ;

Ivy, Percy ;

Scadden, David T. ;

Benner, Thomas ;

Loeffler, Jay S. ;

Wen, Patrick Y. ;

Jain, Rakesh K. .

CANCER CELL, 2007, 11 (01) :83-95

[2]

Chakravarti A, 2002, CANCER RES, V62, P200

[3] Bevacizumab plus irinotecan in recurrent glioblastoma [J].

Chamberlain, Marc C. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) :1012-1013

[4] Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells [J].

Davis, Faith B. ;

Tang, Heng-Yuan ;

Shih, Ai ;

Keating, Travis ;

Lansing, Lawrence ;

Hercbergs, Aleck ;

Fenstermaker, Robert A. ;

Mousa, Ahmed ;

Mousa, Shaker A. ;

Davis, Paul J. ;

Lin, Hung-Yun .

CANCER RESEARCH, 2006, 66 (14) :7270-7275

[5]

Davis Paul J, 2006, Expert Rev Endocrinol Metab, V1, P753, DOI 10.1586/17446651.1.6.753

[6] Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR [J].

Davis, PJ ;

Shih, A ;

Lin, HY ;

Martino, LJ ;

Davis, FB .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) :38032-38039

[7]

Hercbergs A, 2008, AM ASS CANC RES ANN

[8] Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways [J].

Miele, C ;

Rochford, JJ ;

Filippa, N ;

Giorgetti-Peraldi, S ;

Van Obberghen, E .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (28) :21695-21702

[9]

Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514

[10] Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence [J].

Norden, A. D. ;

Young, G. S. ;

Setayesh, K. ;

Muzikansky, A. ;

Klufas, R. ;

Ross, G. L. ;

Ciampa, A. S. ;

Ebbeling, L. G. ;

Levy, B. ;

Drappatz, J. ;

Kesari, S. ;

Wen, P. Y. .

NEUROLOGY, 2008, 70 (10) :779-787

← 1 2 →